Evolve HESI Practice Exam 2025 - Free HESI Practice Questions and Study Guide

Monitoring for signs of bleeding is crucial in patients receiving anticoagulants because these medications are designed to inhibit the blood's ability to clot. While anticoagulants effectively prevent thromboembolic events, they also increase the risk of abnormal bleeding. This could present as easy bruising, prolonged bleeding from cuts, blood in the urine or stool, or unusual bleeding from the gums. Regular assessments for these signs allow for timely intervention, ensuring patient safety and adjusting treatment as necessary.

The other options, though important in different contexts, do not directly address the primary concern associated with anticoagulant therapy. Signs of infection are monitored for other medications or conditions but are not specifically tied to anticoagulant effects. Patient weight is important for general health but is not a direct indicator of anticoagulant efficacy or safety. Urine output is significant in assessing renal function or hydration status but does not reflect the risk of bleeding associated with anticoagulant use.